Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 18, 2017
Pharmacy Choice - Pharmaceutical News - 15 Biggest Mid-Day Gainers For Tuesday - November 18, 2017

Pharmacy News Article

 9/12/17 - 15 Biggest Mid-Day Gainers For Tuesday
  • Forward Pharma A/S (NASDAQ: FWP) shares jumped 66.6 percent to $8.61.
  • Aldeyra Therapeutics Inc (NASDAQ: ALDX) surged 57.9 percent to $6.63. Aldeyra Therapeutics disclosed 'positive' results from dry eye disease Phase 2a clinical trial.
  • Aethlon Medical, Inc. (NASDAQ: AEMD) shares climbed 50.6 percent to $3.01 after the company disclosed Expedited Access Pathway designation from the FDA to accelerate US access to Hemopurifier.
  • Quotient Ltd (NASDAQ: QTNT) shares gained 28.1 percent to $4.75 after the company reports results from latest MosaiQ performance evaluation studies prior to commencing verification and validation studies.
  • SAExploration Holdings, Inc. (NASDAQ: SAEX) shares rose 20 percent to $2.87.
  • Inovalon Holdings Inc (NASDAQ: INOV) shares surged 17.6 percent to $17.23. Morgan Stanley upgraded Inovalon Holdings from Underweight to Equal-Weight and raised the price target from $9.00 to $14.00.
  • Forterra Inc (NASDAQ: FRTA) shares rose 15.8 percent to $4.90.
  • Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares surged 10 percent to $5.29.
  • Citius Pharmaceuticals Inc (NASDAQ: CTXR) shares rose 9.5 percent to $3.50.
  • Baozun Inc (ADR) (NASDAQ: BZUN) shares climbed 8.3 percent to $34.82.
  • Pier 1 Imports Inc (NYSE: PIR) shares rose 6.8 percent to $4.64.
  • MasTec, Inc. (NYSE: MTZ) climbed 6.1 percent to $43.40. Deutsche Bank upgraded MasTec from Hold to Buy.
  • Comerica Incorporated (NYSE: CMA) rose 3.8 percent to $69.29. Piper Jaffray upgraded Comerica from Neutral to Overweight.
  • Alcoa Corp (NYSE: AA) surged 3.2 percent to $44.99. Deutsche Bank upgraded Alcoa from Hold to Buy.
  • Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) gained 3.1 percent to $19.07 after surging 19.35 percent on Monday. The company reported the sale of PARAGARD to CooperSurgical for $1.1 billion in cash.

Write to editorial@benzinga.com with any questions about this content. Subscribe to Benzinga Pro: http://pro.benzinga.com

© 2015 Benzinga Newswires. Benzinga does not provide investment advice. All rights reserved.




Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Nov 19: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Nov 20: Obesity Management: Overview of Pharmacotherapy
Nov 21: Standards of Practice for Filling Controlled Substance Prescriptions in Florida
Nov 22: Medical Marijuana: Examining the Science, Not the Politics
Nov 27: Drug Diversion and the Law: Updates and Considerations
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415